Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Surgery. 2014 Jun 21;156(2):263–269. doi: 10.1016/j.surg.2014.03.031

Figure 3.

Figure 3

GLV-1h68 demonstrates the ability to replicate in both parental and sorafenib-resistant HCC cell lines in-vitro. Viral replication is supported by all HCC cell lines in-vitro. Standard viral plaque assay of cells infected with an MOI of 1.0 demonstrate increase in viral titers over 5 days in all 8 cell lines tested.